Trans-Tranilast

CAS No. 70806-55-2

Trans-Tranilast( Tranilast | Rizaben | SB-252218 | SB 252218 | SB252218 )

Catalog No. M15716 CAS No. 70806-55-2

Trans-Tranilast is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
10MG 78 In Stock
25MG 133 In Stock
50MG 213 In Stock
100MG 318 In Stock
200MG 471 In Stock
500MG 753 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Trans-Tranilast
  • Note
    Research use only, not for human use.
  • Brief Description
    Trans-Tranilast is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis.
  • Description
    Trans-Tranilast is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Tranilast | Rizaben | SB-252218 | SB 252218 | SB252218
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    Angiotensin Receptor
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    70806-55-2
  • Formula Weight
    327.33
  • Molecular Formula
    C18H17NO5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(O)C1=CC=CC=C1NC(/C=C/C2=CC=C(OC)C(OC)=C2)=O
  • Chemical Name
    (E)-2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino]benzoic Acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rogosnitzky, MR, et al. anticancer Res, 2012. 32(7): p. 2471-8. 2. Swiderski, K, et al. Fibrogenesis Tissue Repair, 2014. 7(1): p.
molnova catalog
related products
  • Breviscapin

    Breviscapine is the total flavonoid components (the content of scutellarin > or =85%) extracted from the dried whole plant of Erigeron breviscapus.

  • Terlakiren

    Terlakiren (CP-80,794) is an orally active, potent renin inhibitor used in the study of neurological disorders related to hypertension.

  • ANGIOTENSIN IV TFA

    ANGIOTENSIN IV TFA is a less effective agonist at the angiotensin AT1 receptor.